{'fraction_non_alphanumeric': 0.020161290322580645, 'fraction_numerical': 0.008064516129032258, 'mean_word_length': 5.291139240506329, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Patients benefit from using own CD4 T-cells.

HIV researchers continue to explore novel ways to fight the disease and enhance the benefits of antiretroviral therapy. One new approach involves the transferring activated autologous CD4 T-cells into HIV-infected patients with the goal of augmenting natural immunity to HIV infection. Reconstituting CD4 helper cell activity, along with decreasing CCR5 expression, may augment natural immunity to HIV infection, according to a newly published study.